Stocks

IREDA, Cello, and Mamaearth Eye MSCI Index Inclusions while Nykaa and Mankind Pharma May Need Further Rally

Published January 7, 2024

The positioning of companies in global market indices, such as MSCI and FTSE, is a critical factor influencing the flow of passive investment funds. Inclusions and increased weightage could attract considerable inflows, while exclusions lead to the opposite effect. As a company finds its way into these prestigious indices or ups its share in them, it typically reaps the benefits of enhanced liquidity and attractiveness to a broader investor base, particularly passive funds that mirror the performance of these indices.

Understanding Market Index Inclusions and Exclusions

Index inclusions are often seen as a nod of confidence in a company's market capitalization and liquidity, enhancing its visibility in the global investment community. Organizations such as IREDA, Cello, and Mamaearth have been identified as potential candidates for inclusion in the MSCI index. Their inclusion could mean that indexed funds would automatically allocate investments to these stocks, fostering increased demand and potentially elevating the share price.

Impact on Individual Stocks

Conversely, for consumer brands like Nykaa and Mankind Pharma, a need to rally further is indicated. Their current performance may not suffice for index inclusion or weightage increase, implying that without additional momentum, they could see a resulting constraint in passive fund inflows. As such, the recent news about potential changes in MSCI index compositions has been closely monitored by investors, given its implications for stock movements.

inclusion, indices, investment